Related Experiment Video
Updated: Mar 21, 2026
07:51
The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
Published on: June 1, 2019
21.9K
Completion Lymph Node Dissection or Observation for Melanoma Sentinel Lymph Node Metastases: A Decision Analysis.
Erin E Burke1, Pamela R Portschy1, Todd M Tuttle2,3
1Department of Surgery, University of Minnesota, Minneapolis, MN, USA.
Annals of Surgical Oncology
|May 20, 2016
Summary
Immediate completion lymph node dissection (CLND) for melanoma patients with sentinel lymph node (SLN) metastases improves overall survival and quality-adjusted life expectancy compared to observation. This approach offers significant life-years gained, particularly for younger patients.
Area of Science:
- Oncology
- Surgical Oncology
- Decision Analysis
Background:
- Lack of long-term trial data comparing completion lymph node dissection (CLND) versus observation for sentinel lymph node (SLN) metastases in melanoma.
- Need to establish optimal management for melanoma patients with positive SLN biopsy results.
Purpose of the Study:
- To determine the optimal management strategy for melanoma patients with sentinel lymph node (SLN) metastases: immediate completion lymph node dissection (CLND) or observation.
- To evaluate the impact of each strategy on survival and quality of life.
Main Methods:
- Development of a Markov model to simulate patient prognosis.
- Inclusion of parameters such as non-SLN metastasis rates, melanoma mortality, CLND complication rates, and quality-of-life weights.
- Simulation of hypothetical cohorts undergoing immediate CLND versus observation with delayed CLND.
Main Results:
- Immediate CLND projected a 5-year overall survival of 67.2% versus 63.1% for observation in 50-year-old patients.
- Life expectancy gains from immediate CLND ranged from 2.19 years (age 30) to 0.64 years (age 70).
- Quality-adjusted life expectancy gains ranged from 1.39 QALE (age 30) to 0.36 QALE (age 70).
Conclusions:
- Immediate CLND following a positive SLN biopsy is associated with gains in overall survival and quality-adjusted life expectancy compared to observation.
- The benefit of immediate CLND is most pronounced in younger patients.
- Sensitivity analysis indicated that increased long-term complication rates or decreased quality-of-life weights could diminish the benefit of immediate CLND.
